Delivery Order SPE2DB22D2206-SPE2DB25FGL11
Award Date
4/7/25
Potential Completion Date
4/28/25
Potential Value
$21K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ENHERTU 100 MG VIALS. The contract has a firm fixed price of $10,666.20 and a period of performance through February 28, 2025. This Delivery Order falls under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,110.80, is for the delivery of ENHERTU 100 MG VIALS, a pharmaceutical product. The contract is a firm fixed-price delivery order, with a performance period ending on May 22, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $17,777.00 firm fixed price contract is for ENHERTU 100 MG VIALS, a medication, with a period of performance through February 6, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award, valued at $14,221.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENHERTU 100 MG VIALS, a pharmaceutical product, with a period of performance through June 2, 2025. The contract is a Delivery Order and is priced on a Firm Fixed Price basis. It is not designated as a set-aside contract, indicating open competition....
This federal contract award, valued at $10,099.62, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENHERTU 100 mg vials, a specialty pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of January 13, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
This is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The $3,223.56 contract is for the delivery of ENHERTU 100 MG VIALS, a pharmaceutical product. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ENHERTU 100 MG VIALS. The firm-fixed-price contract has a ceiling value of $7,110.80 and an ultimate completion date of April 14, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $19,341.24 firm fixed-price contract is for the supply of ENHERTU 100 MG VIALS, a pharmaceutical product. The delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,087,734 units of the prescription drug ENHERTU 100 MG VIALS. The contract has a firm fixed price of $21,332.40 and a period of performance through May 21, 2025. The award is not designated as a set-aside. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC)...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ENHERTU 100 mg vials. The $26,932.32 firm fixed-price contract has an ultimate completion date of January 6, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...